{"organizations": [], "uuid": "d8067281e73fad0ffcb39395435fe690cc064d3a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cannaroyalty-and-aequus-pharmaceut/brief-cannaroyalty-and-aequus-pharmaceuticals-announce-jv-to-develop-and-commercialize-cannabis-based-therapies-targeting-neurological-disorders-idUSFWN1P60E6", "country": "US", "domain_rank": 408, "title": "BRIEF-Cannaroyalty And Aequus Pharmaceuticals Announce JV To Develop And Commercialize Cannabis-Based Therapies Targeting Neurological Disorders", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-11T13:10:00.000+02:00", "replies_count": 0, "uuid": "d8067281e73fad0ffcb39395435fe690cc064d3a"}, "author": "", "url": "https://www.reuters.com/article/brief-cannaroyalty-and-aequus-pharmaceut/brief-cannaroyalty-and-aequus-pharmaceuticals-announce-jv-to-develop-and-commercialize-cannabis-based-therapies-targeting-neurological-disorders-idUSFWN1P60E6", "ord_in_thread": 0, "title": "BRIEF-Cannaroyalty And Aequus Pharmaceuticals Announce JV To Develop And Commercialize Cannabis-Based Therapies Targeting Neurological Disorders", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "aequus pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 10 AM / Updated 15 minutes ago BRIEF-Cannaroyalty And Aequus Pharmaceuticals Announce JV To Develop And Commercialize Cannabis-Based Therapies Targeting Neurological Disorders Reuters Staff 1 Min Read \nJan 11 (Reuters) - Aequus Pharmaceuticals Inc: \n* CANNAROYALTY AND AEQUUS PHARMACEUTICALS ANNOUNCE JOINT VENTURE TO DEVELOP AND COMMERCIALIZE CANNABIS-BASED THERAPIES TARGETING NEUROLOGICAL DISORDERS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-11T13:10:00.000+02:00", "crawled": "2018-01-11T13:31:31.012+02:00", "highlightTitle": ""}